No Data
No Data
Oppenheimer Maintains Veru Inc(VERU.US) With Buy Rating, Cuts Target Price to $4
Express News | Veru : Oppenheimer Cuts Target Price to $4 From $5
Earnings Call Summary | Veru Inc(VERU.US) Q1 2025 Earnings Conference
Veru Inc | 10-Q: Q1 2025 Earnings Report
Veru Targets Phase 3 Enobosarm Trials Following Promising Phase 2b Results in Obesity Treatment
Earnings Preview: Veru Inc to Report Financial Results on February 13
Unlock the Full List